Item request has been placed!
×
Item request cannot be made.
×
Processing Request
An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
- Publication Information:
Original Publication: Washington, DC : National Academy of Sciences
- Subject Terms:
- Abstract:
In humans, septal defects are among the most prevalent congenital heart diseases, but their cellular and molecular origins are not fully understood. We report that transcription factor Tbx5 is present in a subpopulation of endocardial cells and that its deletion therein results in fully penetrant, dose-dependent atrial septal defects in mice. Increased apoptosis of endocardial cells lacking Tbx5, as well as neighboring TBX5-positive myocardial cells of the atrial septum through activation of endocardial NOS (Nos3), is the underlying mechanism of disease. Compound Tbx5 and Nos3 haploinsufficiency in mice worsens the cardiac phenotype. The data identify a pathway for endocardial cell survival and unravel a cell-autonomous role for Tbx5 therein. The finding that Nos3, a gene regulated by many congenital heart disease risk factors including stress and diabetes, interacts genetically with Tbx5 provides a molecular framework to understand gene-environment interaction in the setting of human birth defects.
- References:
Dev Biol. 2006 Sep 15;297(2):566-86. (PMID: 16870172)
J Am Coll Cardiol. 2005 Jul 5;46(1):1-8. (PMID: 15992627)
Curr Biol. 1998 Feb 26;8(5):299-302. (PMID: 9501070)
Development. 2002 Sep;129(17):4045-55. (PMID: 12163407)
Circulation. 1998 May 26;97(20):2043-8. (PMID: 9610535)
Dev Biol. 2008 May 1;317(1):282-95. (PMID: 18353304)
Cardiovasc Pathol. 2008 Jan-Feb;17(1):48-54. (PMID: 18160060)
Cell. 2006 May 5;125(3):593-605. (PMID: 16678101)
Circulation. 2007 Jun 12;115(23):3015-38. (PMID: 17519398)
J Exp Med. 1997 Feb 17;185(4):601-7. (PMID: 9034139)
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):814-9. (PMID: 19129488)
Cell Tissue Res. 2001 Jul;305(1):67-78. (PMID: 11512673)
Int J Cardiol. 2008 Oct 30;130(1):30-5. (PMID: 18706711)
Dev Cell. 2006 Nov;11(5):723-32. (PMID: 17084363)
Circulation. 2002 Aug 13;106(7):873-9. (PMID: 12176963)
Hum Mutat. 2004 Jul;24(1):104. (PMID: 15221798)
PLoS Genet. 2007 Aug;3(8):e140. (PMID: 17722983)
Circulation. 1985 Apr;71(4):745-53. (PMID: 3971543)
Hypertension. 2003 Oct;42(4):737-43. (PMID: 12860836)
Cell. 2001 Sep 21;106(6):709-21. (PMID: 11572777)
Dev Biol. 2003 Feb 1;254(1):131-48. (PMID: 12606287)
Nature. 1998 Mar 12;392(6672):182-6. (PMID: 9515963)
J Physiol. 2003 Jan 1;546(Pt 1):63-75. (PMID: 12509479)
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6502-7. (PMID: 15096597)
Nature. 2003 Jul 24;424(6947):443-7. (PMID: 12845333)
Mol Cell Biol. 2008 Jun;28(12):4052-67. (PMID: 18391012)
Kidney Int. 2009 Feb;75(3):327-32. (PMID: 19037250)
Heart Fail Rev. 2003 Jan;8(1):23-8. (PMID: 12652156)
Dev Biol. 1999 Jul 1;211(1):100-8. (PMID: 10373308)
Development. 2006 Sep;133(18):3607-18. (PMID: 16914500)
Dev Biol. 2009 Feb 15;326(2):368-77. (PMID: 19084512)
Am J Hum Genet. 2003 Jul;73(1):74-85. (PMID: 12789647)
Nature. 2008 Feb 21;451(7181):943-8. (PMID: 18288184)
Nature. 1996 Apr 25;380(6576):711-4. (PMID: 8614465)
Circulation. 2007 Jun 12;115(23):2995-3014. (PMID: 17519397)
Proc Natl Acad Sci U S A. 2004 May 4;101(18):6975-80. (PMID: 15100413)
Dev Biol. 2007 Feb 15;302(2):376-88. (PMID: 17064679)
Dev Biol. 2007 Jun 1;306(1):179-92. (PMID: 17449024)
J Am Coll Cardiol. 2002 Jun 19;39(12):1890-900. (PMID: 12084585)
J Biol Chem. 1995 Jun 23;270(25):15320-6. (PMID: 7541039)
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3058-63. (PMID: 9096345)
N Engl J Med. 2000 Jan 27;342(4):256-63. (PMID: 10648769)
Development. 2005 May;132(10):2463-74. (PMID: 15843409)
Blood. 2007 Jun 1;109(11):4742-52. (PMID: 17299096)
Development. 2004 Jul;131(13):3081-91. (PMID: 15175246)
Am J Physiol Cell Physiol. 2002 Jun;282(6):C1348-60. (PMID: 11997250)
J Am Coll Cardiol. 2003 Sep 3;42(5):942-51. (PMID: 12957447)
Cell. 2008 Dec 12;135(6):1053-64. (PMID: 19070576)
Curr Opin Cardiol. 2004 May;19(3):211-5. (PMID: 15096952)
Development. 2005 Mar;132(5):1137-46. (PMID: 15689382)
Development. 1994 Dec;120(12):3361-6. (PMID: 7821208)
Circ Res. 2007 Mar 30;100(6):856-63. (PMID: 17303760)
Clin Chem Lab Med. 2008;46(10):1369-75. (PMID: 18844489)
Dev Dyn. 2000 Apr;217(4):327-42. (PMID: 10767078)
Cell. 2004 Sep 3;118(5):649-63. (PMID: 15339668)
- Grant Information:
GMH79045 Canada Canadian Institutes of Health Research; MOP13057 Canada Canadian Institutes of Health Research
- Accession Number:
0 (GATA4 Transcription Factor)
0 (T-Box Domain Proteins)
0 (T-box transcription factor 5)
EC 1.14.13.39 (Nitric Oxide Synthase Type III)
EC 1.14.13.39 (Nos3 protein, mouse)
- Publication Date:
Date Created: 20101027 Date Completed: 20101230 Latest Revision: 20211020
- Publication Date:
20240829
- Accession Number:
PMC2984205
- Accession Number:
10.1073/pnas.0914888107
- Accession Number:
20974940
No Comments.